From: High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
Study (Ref)
Year
Grade II SP-EPN
Grade III SP-EPN
Total cases
Scheil et al. [11]
2001
1
2
Ghasemi et al. [5]
2019
3
10
13
Swanson et al. [12]
0
4
Raffeld et al
CURRENT
8
